, Singapore

Singapore issuers amongst those that will dominate IPO pipeline by 2030

The city ranks seventh in capital-raising activity.

Singapore is ranked seventh amongst the countries that are projected to lead capital raising activites by 2030, according to a report from PwC. 

In a survey of nearly 400 executives, 12% believe that the most number of issuers will come from Singapore, a ranking that the city shares with Mexico. This puts the city ahead of Japan (11%), South Africa (9%) and Indonesia (8%). 

China nabs the top spot (55%) followed by India (45%). The US, Brazil, and UK round out the top five. 

“Companies from the East are expected to dominate the IPO pipeline by 2025. China was predicted by around 80% of respondents to be the home of most new issuers by 2025. India came second in terms of issuers, but third in
terms of capital," the report's authors said. 

The report also noted that the Singapore bourse is making headway in improving its attractiveness to issuers as it is forecasted to move up to ninth preferred listing destination by 2030 from the current eleventh place.

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare